Belite Bio (BLTE US): Lead Drug Candidate Tapping into Niche Market with Massive Opportunity
Belite’s lead candidate LBS-008 is targeting unmet market for AMD. With no approved drug for either of the targeted indications, LBS-008 has...
No more insights